Company Encyclopedia
View More
name
CheezhengTTM
002287.SZ
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. The company also provides plasters and ointments. Its products are used in areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors.
3.157 T
002287.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking22/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE14.14%B
    • Profit Margin25.63%A
    • Gross Margin82.33%A
  • Growth ScoreC
    • Revenue YoY5.22%C
    • Net Profit YoY3.09%C
    • Total Assets YoY1.66%C
    • Net Assets YoY24.04%A
  • Cash ScoreC
    • Cash Flow Margin390.11%C
    • OCF YoY5.22%C
  • Operating ScoreC
    • Turnover0.36C
  • Debt ScoreB
    • Gearing Ratio26.92%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CheezhengTTM released its performance for the first three quarters, with a net profit attributable to the parent company of 424 million yuan, a year-on-year increase of 7.66%

    According to the Zhitong Finance APP, CheezhengTTM released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.523 billion yuan, a year-on-year increase of 3.48%. The net profit attributable to shareholders of the listed company was 424 million yuan, a year-on-year increase of 7.66%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 282 million yuan, a year-on-year increase of 4.21%

    Zhitong·
    SZ
    002287
    -0.40%
    Zhitong·
    SZ
    002287
    -0.40%

    CheezhengTTM: "Cheezheng Convertible Bonds" have only half a trading day left before trading is suspended

    CheezhengTTM announced at noon on August 28 that "Cheezheng Convertible Bonds" have only half a trading day left before trading is suspended, specifically during the afternoon trading session on August 28. After the market closes on August 28, "Cheezheng Convertible Bonds" will cease trading. September 2 is the last conversion day for "Cheezheng Convertible Bonds," and investors holding "Cheezheng Convertible Bonds" can still convert their bonds before the market closes on that day; after the market closes on September 2, any "Cheezheng Convertible Bonds" that have not been converted will stop conversion. After the market closes on August 28, there are only 3 trading days left before the "Cheezheng Convertible Bonds" stop conversion and are redeemed

    Zhitong·
    SZ
    002287
    -0.40%
    Zhitong·
    SZ
    002287
    -0.40%

    CheezhengTTM released its performance for the first half of the year, with a net profit attributable to the parent company of 358 million yuan, an increase of 10.04%

    CheezhengTTM released its 2025 semi-annual report, with operating revenue of 1.175 billion yuan, a year-on-year increase of 16.36%; net profit attributable to the parent company was 358 million yuan, a year-on-year increase of 10.04%. The net profit after deducting non-recurring gains and losses was 289 million yuan, a year-on-year increase of 27.36%. The basic earnings per share were 0.6756 yuan, and it plans to distribute a cash dividend of 2.20 yuan (including tax) for every 10 shares to all shareholders

    Zhitong·
    SZ
    002287
    -0.40%
    Zhitong·
    SZ
    002287
    -0.40%

    CheezhengTTM: Early redemption of "Cheezheng convertible bonds," reminding investors to convert shares in a timely manner

    Tibet Cheezheng TTM Pharmaceutical Co., Ltd. issued the fifth notice for the early redemption of "Cheezheng Convertible Bonds." From July 21, 2025, to August 11, the company's stock price triggered the conditional redemption clause, and the board of directors decided to redeem early. The redemption price is 101.701 yuan per bond, the redemption date is September 3, and the last trading day is August 29. "Cheezheng Convertible Bonds" that have not been converted into shares by the close of trading on September 2 will be forcibly redeemed, and after the redemption is completed, they will be delisted from the Shenzhen Stock Exchange

    Zhitong·
    SZ
    002287
    -0.40%
    Zhitong·
    SZ
    002287
    -0.40%

    CheezhengTTM: The shareholding ratio of the controlling shareholder and its concerted parties has been passively diluted

    The shareholding ratio of Qizheng Group, the controlling shareholder of Qizheng Pharmaceutical, and its concerted party Yutuo Culture has been diluted due to the conversion of bonds. From August 8 to 14, 2025, Qizheng convertible bonds converted a total of 13,517,379 shares, increasing the total share capital from 545,606,156 shares to 559,123,535 shares. The shareholding ratio of Qizheng Group decreased from 66.81% to 65.20%, and Yutuo Culture decreased from 18.03% to 17.60%, totaling a decrease from 84.85% to 82.80%

    Zhitong·
    SZ
    002287
    -0.40%
    Zhitong·
    SZ
    002287
    -0.40%
    © 2025 Longbridge｜Disclaimer